What is s@ma?

S@maglutide is a medication that works by mimicking hormones that control blood sugar levels in people with diabetes.

The medication has also been found to affect appetite resulting in fewer cravings, a change in preferences away from fatty foods and less overall energy intake.

In one study, participants lost on average 15 per cent of their body weight while taking the drug.

Who is using s@ma?

s@maglutide has been available in Australia since 2019 and is used by Type-2 diabetics to manage blood sugar levels.

But in recent years, the drug has gained popularity in Australia to treat obesity.

Melbourne resident Rachel* began using the drug out of a desire to lose weight.

“Even people who are a part of the fat acceptance movement have reached that mental point, after years and years of dieting and then regaining that weight, or dieting and losing a little bit, and then plateauing,” she said.

“Always struggling with this niggling sense of hunger that you just can’t let go of.”

Rachel discovered s@ma through a New York Times article, one that reported measurable weight loss for those who took it in clinical trials.

Her GP had never even heard of the drug from the article when Rachel raised it, and she had to be referred to a specialist to obtain it.

Dosage – advice can be found on google.